Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Jul 25;26(1):225.
doi: 10.1186/s13054-022-04086-x.

Acute kidney injury in critical COVID-19: a multicenter cohort analysis in seven large hospitals in Belgium

Affiliations
Multicenter Study

Acute kidney injury in critical COVID-19: a multicenter cohort analysis in seven large hospitals in Belgium

Hannah Schaubroeck et al. Crit Care. .

Abstract

Background: Acute kidney injury (AKI) has been reported as a frequent complication of critical COVID-19. We aimed to evaluate the occurrence of AKI and use of kidney replacement therapy (KRT) in critical COVID-19, to assess patient and kidney outcomes and risk factors for AKI and differences in outcome when the diagnosis of AKI is based on urine output (UO) or on serum creatinine (sCr).

Methods: Multicenter, retrospective cohort analysis of patients with critical COVID-19 in seven large hospitals in Belgium. AKI was defined according to KDIGO within 21 days after ICU admission. Multivariable logistic regression analysis was used to explore the risk factors for developing AKI and to assess the association between AKI and ICU mortality.

Results: Of 1286 patients, 85.1% had AKI, and KRT was used in 9.8%. Older age, obesity, a higher APACHE II score and use of mechanical ventilation at day 1 of ICU stay were associated with an increased risk for AKI. After multivariable adjustment, all AKI stages were associated with ICU mortality. AKI was based on sCr in 40.1% and UO in 81.5% of patients. All AKI stages based on sCr and AKI stage 3 based on UO were associated with ICU mortality. Persistent AKI was present in 88.6% and acute kidney disease (AKD) in 87.6%. Rapid reversal of AKI yielded a better prognosis compared to persistent AKI and AKD. Kidney recovery was observed in 47.4% of surviving AKI patients.

Conclusions: Over 80% of critically ill COVID-19 patients had AKI. This was driven by the high occurrence rate of AKI defined by UO criteria. All AKI stages were associated with mortality (NCT04997915).

Keywords: Acute kidney injury; COVID-19; Epidemiology; Intensive care unit; KDIGO; Kidney replacement therapy; Mortality; Renal replacement therapy; Serum creatinine; Urine output.

PubMed Disclaimer

Conflict of interest statement

EH received Speakers fees from Alexion, Sopachem and Astute Medical paid to the institution and a travel grant from AM Pharma. All other authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
Study flowchart. Flowchart summarizing patient selection and inclusion process as well as number of patients with AKI according to the full KDIGO definition, to sCr or to UO criteria
Fig. 2
Fig. 2
Occurrence rate and ICU mortality of AKI stages. a Occurrence rate and b ICU mortality of AKI stages defined according to the full KDIGO definition and its components AKI-sCr and AKI-UO. AKI = acute kidney injury, AKI-sCr = AKI based on creatinine criteria only, AKI-UO = AKI based on urine output criteria only. Statistical significance of comparison of ICU mortality in AKI-sCr versus AKI-UO stages: AKI stage 0: p = 0.002; AKI stage 1: p < 0.001; AKI stage 2: p = 0.001; AKI stage 3: p = 0.070
Fig. 3
Fig. 3
Association between ICU mortality and AKI stages. Association between ICU mortality and AKI stage according to serum creatinine and/or urine output: a unadjusted, b adjusted

Similar articles

Cited by

References

    1. Panel C-TG. National Institute of Health; 2021. https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treat...
    1. COVID-19 Map [Internet]. Johns Hopkins Coronavirus Resource Center; 2021. https://coronavirus.jhu.edu/map.html
    1. Lumlertgul N, Pirondini L, Cooney E, Kok W, Gregson J, Camporota L, et al. Acute kidney injury prevalence, progression and long-term outcomes in critically ill patients with COVID-19: a cohort study. Ann Intensive Care. 2021;11(1):123. doi: 10.1186/s13613-021-00914-5. - DOI - PMC - PubMed
    1. Bayrakci N, Ozkan G, Sakaci M, Sedef S, Erdem I, Tuna N, et al. The incidence of acute kidney injury and its association with mortality in patients diagnosed with COVID-19 followed up in intensive care unit. Ther apheresis Dial Off Peer-Rev J Int Soc Apheresis Jpn Soc Apheresis Jpn Soc Dial Ther. 2022 doi: 10.1111/1744-9987.13790. - DOI - PubMed
    1. Yu Y, Xu D, Fu S, Zhang J, Yang X, Xu L, et al. Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study. Crit Care (Lond Engl) 2020;24(1):219. doi: 10.1186/s13054-020-02939-x. - DOI - PMC - PubMed

Publication types

Associated data